BridgeMD
New treatment option for Duchenne / Becker Muscular Dystrophy
Official title Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies
ClinicalTrials.gov ID: NCT07415837
What this study is testing
- What it's testing
- The study aims to find out if a specific blood molecule called miR-1, can be used as a biomarker to track the health of patients with certain muscle diseases. MicroRNAs (miRs) are small messengers that help control how cells grow and stay healthy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 and older. Healthy volunteers may be eligible.
You may be able to join if
- Age: Participants must be older than 2 years of age
- Consent: Participants (or their legal guardians) must provide free and informed consent,. For children, the consent is oral for those under 6 years...
- Social Security: Every participant must be affiliated with the French social security system.
- Participants must have a diagnosed neuromuscular pathology : the eligible pathologies are Myotonic Dystrophy Type 1 (DM1 or Steinert's disease)...
You likely can't join if
- Refusal to participate expressed by the subject or their parental authority.
- Engaging in intense and unusual physical effort within 10 days before the blood draw.
- Current use of any treatment with systemic, muscular, or cardiac effects that could interfere with the study's biological results.
- people or their legal guardians who are under tutelage, curatorship, deprived of liberty, or under judicial protection.
- Women who are pregnant or breastfeeding.
- The presence of an additional pathology that, in the judgment of the clinician, could interfere with the biological findings
The study team makes the final eligibility decision.
Where it's taking place
- Clermont-Ferrand, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Clermont-Ferrand, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.